How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Document

    Do you agree NICE should focus on guidance production and maintenance on priority areas (section 5) and these should be reviewed periodically to ensure NICE is supporting what the health and care system needs? If you disagree, please give reason and rationale.

  • Question on Document

    Do you agree that NICE should be transparent about its remit (section 3.12, section 6.1.1 and 6.2)? If you disagree, please give reason and rationale.

  • Question on Document

    Do you think the new process and consideration factors for NICE to propose topics to the Secretary of State for NHAP are robust and transparent (section 4 and Annex A)? If you disagree, please give reason and rationale. Are there any other factors NICE should include to consider?

  • Question on Document

    Do you think the new merged single-stage prioritisation framework is more streamlined and efficient for topic selection? If you disagree, please give reason and rationale.

NICE-wide topic prioritisation: the manual

Open for comments Open until   Request commenting lead permission

We have updated this service so that members of the same organisation can now collaborate on a joint online response.

Read our blog to learn more.

4 Summary of the NICE-wide topic prioritisation process

The NICE-wide topic prioritisation process is designed to ensure that NICE guidance reflects priority areas for health and care, in line with NICE's principles. The process involves the following:

The 2024 voluntary scheme for branded medicines, pricing, access and growth states that NICE will continue to evaluate all new active substances and significant indications, except where there is a clear rationale not to do so. These new active substances and significant indications will not go through the NICE-wide topic prioritisation process and will be routed to technology appraisal guidance, except when there is a clear rationale not to do so.

The NICE prioritisation board will make highly specialised technologies routing decisions using the highly specialised technologies: NICE prioritisation board routing criteria).

After a HealthTech topic is prioritised by the NICE prioritisation board for guidance development, the NICE prioritisation board will also make further proposals to the Secretary of State for HealthTech topics using NICE's technology appraisal process (see annex A on the National HealthTech Access Programme).